Avanos Medical (AVNS) Operating Expenses (2013 - 2026)

Avanos Medical has disclosed Operating Expenses across 14 years of filings, most recently posting $82.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 2.22% year-over-year to $82.9 million; the TTM figure through Mar 2026 stood at $340.7 million (up 1.64% YoY), while the FY2025 annual figure was $338.9 million, down 1.68% from the prior year.
• Operating Expenses came in at $82.9 million for Q1 2026 at Avanos Medical, down from $84.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $99.8 million in Q2 2023 to a low of $81.1 million in Q1 2025.
• Average Operating Expenses over 5 years is $87.6 million, with a median of $85.4 million recorded in 2022.
• Year-over-year, Operating Expenses increased 29.95% in 2022 and declined 12.63% in 2024.
• Over 5 years, Operating Expenses stood at $85.9 million in 2022, then declined by 5.36% to $81.3 million in 2023, then gained by 5.04% to $85.4 million in 2024, then retreated by 0.59% to $84.9 million in 2025, then dropped by 2.36% to $82.9 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $82.9 million in Q1 2026, $84.9 million in Q4 2025, and $83.6 million in Q3 2025.